Skip to main content
. 2012 Jan 17;2:227. doi: 10.1038/srep00227

Figure 4. Other reported prognostic signatures fail to predict patient outcome in the context of BLBC.

Figure 4

We calculated a signature index for the (A) Basal 14, (B) Genomic Grade Index, (C) NKI-70, (D) Recurrence Score, (E) CSR/Wound response, (F) Triple Negative and (G) MS-14 signatures. Only the Basal 14 signature was prognostic in the validation cohort of BLBC patients HR: 4.7 [CI95: 1.8–12.3], p = 0.0017, Log-rank test). Although, the Triple negative signature did trend to significance (HR: 2.0 [CI95: 0.8–5.4], p = 0.15, Log-rank test).